Report Detail

Request for Sample of this report

Service & Software Global Blood Proteomics Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4725593
    • |
  • 03 August, 2026
    • |
  • Global
    • |
  • 207 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Blood Proteomics Services market size was valued at US$ 836 million in 2025 and is forecast to a readjusted size of US$ 1774 million by 2032 with a CAGR of 11.6% during review period.
Blood Proteomics Services refer to specialized research services that utilize advanced proteomics technologies to systematically identify, quantify, and interpret proteins from blood-derived biological samples, including plasma, serum, whole blood, and peripheral blood cells.
By analyzing circulating proteins, blood proteomics provides comprehensive insights into physiological conditions, disease progression, therapeutic responses, and biomarker discovery. Compared with genomics and transcriptomics, blood proteomics directly measures functional molecules that execute biological activities, making it highly valuable for understanding disease phenotypes and developing precision medicine solutions.
Blood Proteomics Services typically integrate high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), multiplex immunoassays, proximity extension assays (PEA), and aptamer-based protein profiling technologies. These services cover the complete workflow from blood sample preparation, protein extraction, analytical detection, quantitative profiling, computational analysis, biomarker identification, and biological interpretation.
Currently, blood proteomics services are widely applied in biomarker discovery, clinical trial support, drug mechanism studies, population-scale health research, oncology, cardiovascular disease research, neurological disorders, autoimmune diseases, and precision medicine. With advances in artificial intelligence, large-scale biobanks, and multi-omics integration, blood proteomics has become a critical platform connecting biomedical research with clinical translation.
Blood Proteomics Services primarily operate under a technology-driven CRO model combining advanced analytical platforms, specialized laboratory expertise, and bioinformatics capabilities.
Service providers typically establish integrated infrastructure including mass spectrometry platforms, automated sample preparation systems, protein profiling technologies, and computational analysis pipelines. Typical workflows include study design, blood sample quality control, plasma/serum preparation, depletion of high-abundance proteins, enzymatic digestion, mass spectrometry or affinity-based detection, data processing, statistical analysis, biomarker discovery, and final reporting.
The upstream value chain includes mass spectrometry manufacturers, chromatography suppliers, antibody and reagent providers, aptamer technology companies, bioinformatics software suppliers, and laboratory consumable manufacturers. The midstream consists of proteomics CRO companies, clinical research service providers, and multi-omics analysis platforms. Downstream customers include pharmaceutical companies, biotechnology firms, academic institutions, hospitals, biobanks, and precision medicine organizations.
Blood Proteomics Services represent a high-value-added segment in life science research. Standardized plasma proteomics services generally achieve gross margins of approximately 40%-60%. Advanced services based on deep proteomics, DIA workflows, clinical cohorts, and drug discovery applications typically generate gross margins of 55%-75% due to higher equipment investment, analytical complexity, and data value. Companies with proprietary platforms, databases, computational capabilities, and pharmaceutical partnerships may achieve margins around 70%.
Blood Proteomics Services are becoming a strategic growth area in precision medicine and innovative drug development. As biomedical research moves from genomic information toward functional protein regulation, demand for circulating biomarkers, disease prediction, and treatment response analysis continues to increase.
By enabling large-scale profiling of circulating proteins, blood proteomics can identify disease-related molecular signals that are difficult to capture using traditional approaches. It provides new opportunities in cancer screening, immunotherapy, neurological research, and chronic disease management. The development of large-scale biobanks, artificial intelligence analytics, and multi-omics integration will further accelerate commercialization. Olink platforms have been adopted by pharmaceutical companies and research institutions worldwide to support proteomics research and translational applications.
The blood proteomics service market faces challenges including high analytical costs, extremely broad protein concentration ranges, difficulty detecting low-abundance proteins, and limited standardization among platforms.
High-abundance plasma proteins may interfere with the detection of disease-related low-abundance biomarkers, requiring advanced depletion strategies, deep mass spectrometry workflows, and highly sensitive detection technologies. In addition, complex proteomics datasets require advanced computational capabilities, creating significant entry barriers. Data standards, quality control, and regulatory requirements will become increasingly important as clinical applications expand.
Future demand for Blood Proteomics Services will increasingly focus on clinical translation, population-scale studies, and pharmaceutical applications.
Pharmaceutical companies will utilize blood proteomics for target discovery, mechanism-of-action studies, patient stratification, and companion diagnostic development. Biotechnology companies will increasingly rely on CRO providers to reduce infrastructure investment and accelerate innovation programs. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued growth of precision medicine and AI-driven life sciences, Blood Proteomics Services providers with high-throughput capabilities, advanced analytics, proprietary databases, and global delivery networks will gain stronger competitive positions in the future market.
Report Scope
This report is a detailed and comprehensive analysis for global Blood Proteomics Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Proteomics Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood Proteomics Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Proteomics Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Proteomics Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Proteomics Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Blood Proteomics
Blood Modification Proteomics
Olink (Targeted) Proteomics
Market segment by End User
Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others
Market segment by Research Areas
Oncology
Cardiovascular
Agriculture
Neuroscience
Other
Market segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Market segment by players, this report covers
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Blood Proteomics Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Proteomics Services, with revenue, gross margin, and global market share of Blood Proteomics Services from 2021 to 2026.
Chapter 3, the Blood Proteomics Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood Proteomics Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Proteomics Services.
Chapter 13, to describe Blood Proteomics Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Blood Proteomics Services by Type
    • 1.3.1 Overview: Global Blood Proteomics Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Blood Proteomics Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Blood Proteomics
    • 1.3.4 Blood Modification Proteomics
    • 1.3.5 Olink (Targeted) Proteomics
  • 1.4 Classification of Blood Proteomics Services by End User
    • 1.4.1 Overview: Global Blood Proteomics Services Market Size by End User: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Blood Proteomics Services Consumption Value Market Share by End User in 2025
    • 1.4.3 Universities and Research Institutes
    • 1.4.4 Hospitals
    • 1.4.5 Pharmaceutical Companies
    • 1.4.6 Others
  • 1.5 Classification of Blood Proteomics Services by Research Areas
    • 1.5.1 Overview: Global Blood Proteomics Services Market Size by Research Areas: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Blood Proteomics Services Consumption Value Market Share by Research Areas in 2025
    • 1.5.3 Oncology
    • 1.5.4 Cardiovascular
    • 1.5.5 Agriculture
    • 1.5.6 Neuroscience
    • 1.5.7 Other
  • 1.6 Global Blood Proteomics Services Market by Application
    • 1.6.1 Overview: Global Blood Proteomics Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Disease Biomarker Research
    • 1.6.3 Drug Development
    • 1.6.4 Clinical Research
    • 1.6.5 Others
  • 1.7 Global Blood Proteomics Services Market Size & Forecast
  • 1.8 Global Blood Proteomics Services Market Size and Forecast by Region
    • 1.8.1 Global Blood Proteomics Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Blood Proteomics Services Market Size by Region, (2021-2032)
    • 1.8.3 North America Blood Proteomics Services Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Blood Proteomics Services Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Blood Proteomics Services Market Size and Prospect (2021-2032)
    • 1.8.6 South America Blood Proteomics Services Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Blood Proteomics Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Olink (Thermo Fisher Scientific)
    • 2.1.1 Olink (Thermo Fisher Scientific) Details
    • 2.1.2 Olink (Thermo Fisher Scientific) Major Business
    • 2.1.3 Olink (Thermo Fisher Scientific) Blood Proteomics Services Product and Solutions
    • 2.1.4 Olink (Thermo Fisher Scientific) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Olink (Thermo Fisher Scientific) Recent Developments and Future Plans
  • 2.2 SomaLogic (Illumina)
    • 2.2.1 SomaLogic (Illumina) Details
    • 2.2.2 SomaLogic (Illumina) Major Business
    • 2.2.3 SomaLogic (Illumina) Blood Proteomics Services Product and Solutions
    • 2.2.4 SomaLogic (Illumina) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SomaLogic (Illumina) Recent Developments and Future Plans
  • 2.3 Labcorp
    • 2.3.1 Labcorp Details
    • 2.3.2 Labcorp Major Business
    • 2.3.3 Labcorp Blood Proteomics Services Product and Solutions
    • 2.3.4 Labcorp Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Labcorp Recent Developments and Future Plans
  • 2.4 BostonGene
    • 2.4.1 BostonGene Details
    • 2.4.2 BostonGene Major Business
    • 2.4.3 BostonGene Blood Proteomics Services Product and Solutions
    • 2.4.4 BostonGene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BostonGene Recent Developments and Future Plans
  • 2.5 CellCarta
    • 2.5.1 CellCarta Details
    • 2.5.2 CellCarta Major Business
    • 2.5.3 CellCarta Blood Proteomics Services Product and Solutions
    • 2.5.4 CellCarta Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CellCarta Recent Developments and Future Plans
  • 2.6 GENEWIZ (Azenta Life Sciences)
    • 2.6.1 GENEWIZ (Azenta Life Sciences) Details
    • 2.6.2 GENEWIZ (Azenta Life Sciences) Major Business
    • 2.6.3 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product and Solutions
    • 2.6.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments and Future Plans
  • 2.7 CDI Labs
    • 2.7.1 CDI Labs Details
    • 2.7.2 CDI Labs Major Business
    • 2.7.3 CDI Labs Blood Proteomics Services Product and Solutions
    • 2.7.4 CDI Labs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 CDI Labs Recent Developments and Future Plans
  • 2.8 Biognosys
    • 2.8.1 Biognosys Details
    • 2.8.2 Biognosys Major Business
    • 2.8.3 Biognosys Blood Proteomics Services Product and Solutions
    • 2.8.4 Biognosys Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biognosys Recent Developments and Future Plans
  • 2.9 Discovery Life Sciences
    • 2.9.1 Discovery Life Sciences Details
    • 2.9.2 Discovery Life Sciences Major Business
    • 2.9.3 Discovery Life Sciences Blood Proteomics Services Product and Solutions
    • 2.9.4 Discovery Life Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Discovery Life Sciences Recent Developments and Future Plans
  • 2.10 Firalis Molecular Precision
    • 2.10.1 Firalis Molecular Precision Details
    • 2.10.2 Firalis Molecular Precision Major Business
    • 2.10.3 Firalis Molecular Precision Blood Proteomics Services Product and Solutions
    • 2.10.4 Firalis Molecular Precision Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Firalis Molecular Precision Recent Developments and Future Plans
  • 2.11 Cell Signaling Technology (CST)
    • 2.11.1 Cell Signaling Technology (CST) Details
    • 2.11.2 Cell Signaling Technology (CST) Major Business
    • 2.11.3 Cell Signaling Technology (CST) Blood Proteomics Services Product and Solutions
    • 2.11.4 Cell Signaling Technology (CST) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Cell Signaling Technology (CST) Recent Developments and Future Plans
  • 2.12 Sampled (Infinity Biologix)
    • 2.12.1 Sampled (Infinity Biologix) Details
    • 2.12.2 Sampled (Infinity Biologix) Major Business
    • 2.12.3 Sampled (Infinity Biologix) Blood Proteomics Services Product and Solutions
    • 2.12.4 Sampled (Infinity Biologix) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sampled (Infinity Biologix) Recent Developments and Future Plans
  • 2.13 APTBIO
    • 2.13.1 APTBIO Details
    • 2.13.2 APTBIO Major Business
    • 2.13.3 APTBIO Blood Proteomics Services Product and Solutions
    • 2.13.4 APTBIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 APTBIO Recent Developments and Future Plans
  • 2.14 Sinotech Genomics
    • 2.14.1 Sinotech Genomics Details
    • 2.14.2 Sinotech Genomics Major Business
    • 2.14.3 Sinotech Genomics Blood Proteomics Services Product and Solutions
    • 2.14.4 Sinotech Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Sinotech Genomics Recent Developments and Future Plans
  • 2.15 Biodesix
    • 2.15.1 Biodesix Details
    • 2.15.2 Biodesix Major Business
    • 2.15.3 Biodesix Blood Proteomics Services Product and Solutions
    • 2.15.4 Biodesix Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Biodesix Recent Developments and Future Plans
  • 2.16 Panome Bio
    • 2.16.1 Panome Bio Details
    • 2.16.2 Panome Bio Major Business
    • 2.16.3 Panome Bio Blood Proteomics Services Product and Solutions
    • 2.16.4 Panome Bio Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Panome Bio Recent Developments and Future Plans
  • 2.17 Novogene
    • 2.17.1 Novogene Details
    • 2.17.2 Novogene Major Business
    • 2.17.3 Novogene Blood Proteomics Services Product and Solutions
    • 2.17.4 Novogene Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Novogene Recent Developments and Future Plans
  • 2.18 PTM BIO
    • 2.18.1 PTM BIO Details
    • 2.18.2 PTM BIO Major Business
    • 2.18.3 PTM BIO Blood Proteomics Services Product and Solutions
    • 2.18.4 PTM BIO Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 PTM BIO Recent Developments and Future Plans
  • 2.19 BGI Genomics
    • 2.19.1 BGI Genomics Details
    • 2.19.2 BGI Genomics Major Business
    • 2.19.3 BGI Genomics Blood Proteomics Services Product and Solutions
    • 2.19.4 BGI Genomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 BGI Genomics Recent Developments and Future Plans
  • 2.20 Evotec
    • 2.20.1 Evotec Details
    • 2.20.2 Evotec Major Business
    • 2.20.3 Evotec Blood Proteomics Services Product and Solutions
    • 2.20.4 Evotec Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Evotec Recent Developments and Future Plans
  • 2.21 Metware Biotechnology
    • 2.21.1 Metware Biotechnology Details
    • 2.21.2 Metware Biotechnology Major Business
    • 2.21.3 Metware Biotechnology Blood Proteomics Services Product and Solutions
    • 2.21.4 Metware Biotechnology Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Metware Biotechnology Recent Developments and Future Plans
  • 2.22 MRM Proteomics
    • 2.22.1 MRM Proteomics Details
    • 2.22.2 MRM Proteomics Major Business
    • 2.22.3 MRM Proteomics Blood Proteomics Services Product and Solutions
    • 2.22.4 MRM Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 MRM Proteomics Recent Developments and Future Plans
  • 2.23 Lc-Bio Technologies
    • 2.23.1 Lc-Bio Technologies Details
    • 2.23.2 Lc-Bio Technologies Major Business
    • 2.23.3 Lc-Bio Technologies Blood Proteomics Services Product and Solutions
    • 2.23.4 Lc-Bio Technologies Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.23.5 Lc-Bio Technologies Recent Developments and Future Plans
  • 2.24 Eurofins Scientific
    • 2.24.1 Eurofins Scientific Details
    • 2.24.2 Eurofins Scientific Major Business
    • 2.24.3 Eurofins Scientific Blood Proteomics Services Product and Solutions
    • 2.24.4 Eurofins Scientific Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.24.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.25 MtoZ-Biolabs
    • 2.25.1 MtoZ-Biolabs Details
    • 2.25.2 MtoZ-Biolabs Major Business
    • 2.25.3 MtoZ-Biolabs Blood Proteomics Services Product and Solutions
    • 2.25.4 MtoZ-Biolabs Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.25.5 MtoZ-Biolabs Recent Developments and Future Plans
  • 2.26 Creative Proteomics
    • 2.26.1 Creative Proteomics Details
    • 2.26.2 Creative Proteomics Major Business
    • 2.26.3 Creative Proteomics Blood Proteomics Services Product and Solutions
    • 2.26.4 Creative Proteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.26.5 Creative Proteomics Recent Developments and Future Plans
  • 2.27 Macrogen
    • 2.27.1 Macrogen Details
    • 2.27.2 Macrogen Major Business
    • 2.27.3 Macrogen Blood Proteomics Services Product and Solutions
    • 2.27.4 Macrogen Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.27.5 Macrogen Recent Developments and Future Plans
  • 2.28 TATAA Biocenter
    • 2.28.1 TATAA Biocenter Details
    • 2.28.2 TATAA Biocenter Major Business
    • 2.28.3 TATAA Biocenter Blood Proteomics Services Product and Solutions
    • 2.28.4 TATAA Biocenter Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.28.5 TATAA Biocenter Recent Developments and Future Plans
  • 2.29 OmicScouts (Momentum Biotechnologies)
    • 2.29.1 OmicScouts (Momentum Biotechnologies) Details
    • 2.29.2 OmicScouts (Momentum Biotechnologies) Major Business
    • 2.29.3 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product and Solutions
    • 2.29.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments and Future Plans
  • 2.30 Precision Biomarker Laboratories (PBL)
    • 2.30.1 Precision Biomarker Laboratories (PBL) Details
    • 2.30.2 Precision Biomarker Laboratories (PBL) Major Business
    • 2.30.3 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product and Solutions
    • 2.30.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.30.5 Precision Biomarker Laboratories (PBL) Recent Developments and Future Plans
  • 2.31 Shanghai OE Biotech
    • 2.31.1 Shanghai OE Biotech Details
    • 2.31.2 Shanghai OE Biotech Major Business
    • 2.31.3 Shanghai OE Biotech Blood Proteomics Services Product and Solutions
    • 2.31.4 Shanghai OE Biotech Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.31.5 Shanghai OE Biotech Recent Developments and Future Plans
  • 2.32 RxCelerate
    • 2.32.1 RxCelerate Details
    • 2.32.2 RxCelerate Major Business
    • 2.32.3 RxCelerate Blood Proteomics Services Product and Solutions
    • 2.32.4 RxCelerate Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.32.5 RxCelerate Recent Developments and Future Plans
  • 2.33 Proteomics International
    • 2.33.1 Proteomics International Details
    • 2.33.2 Proteomics International Major Business
    • 2.33.3 Proteomics International Blood Proteomics Services Product and Solutions
    • 2.33.4 Proteomics International Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.33.5 Proteomics International Recent Developments and Future Plans
  • 2.34 Proteome Sciences
    • 2.34.1 Proteome Sciences Details
    • 2.34.2 Proteome Sciences Major Business
    • 2.34.3 Proteome Sciences Blood Proteomics Services Product and Solutions
    • 2.34.4 Proteome Sciences Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.34.5 Proteome Sciences Recent Developments and Future Plans
  • 2.35 Westlake Omics
    • 2.35.1 Westlake Omics Details
    • 2.35.2 Westlake Omics Major Business
    • 2.35.3 Westlake Omics Blood Proteomics Services Product and Solutions
    • 2.35.4 Westlake Omics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.35.5 Westlake Omics Recent Developments and Future Plans
  • 2.36 Crown Bioscience
    • 2.36.1 Crown Bioscience Details
    • 2.36.2 Crown Bioscience Major Business
    • 2.36.3 Crown Bioscience Blood Proteomics Services Product and Solutions
    • 2.36.4 Crown Bioscience Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.36.5 Crown Bioscience Recent Developments and Future Plans
  • 2.37 VProteomics
    • 2.37.1 VProteomics Details
    • 2.37.2 VProteomics Major Business
    • 2.37.3 VProteomics Blood Proteomics Services Product and Solutions
    • 2.37.4 VProteomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.37.5 VProteomics Recent Developments and Future Plans
  • 2.38 Shanghai Majorbio Bio-Pharm
    • 2.38.1 Shanghai Majorbio Bio-Pharm Details
    • 2.38.2 Shanghai Majorbio Bio-Pharm Major Business
    • 2.38.3 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product and Solutions
    • 2.38.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.38.5 Shanghai Majorbio Bio-Pharm Recent Developments and Future Plans
  • 2.39 Applied Biomics
    • 2.39.1 Applied Biomics Details
    • 2.39.2 Applied Biomics Major Business
    • 2.39.3 Applied Biomics Blood Proteomics Services Product and Solutions
    • 2.39.4 Applied Biomics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.39.5 Applied Biomics Recent Developments and Future Plans
  • 2.40 Sapient Bioanalytics
    • 2.40.1 Sapient Bioanalytics Details
    • 2.40.2 Sapient Bioanalytics Major Business
    • 2.40.3 Sapient Bioanalytics Blood Proteomics Services Product and Solutions
    • 2.40.4 Sapient Bioanalytics Blood Proteomics Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.40.5 Sapient Bioanalytics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Blood Proteomics Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Blood Proteomics Services by Company Revenue
    • 3.2.2 Top 3 Blood Proteomics Services Players Market Share in 2025
    • 3.2.3 Top 6 Blood Proteomics Services Players Market Share in 2025
  • 3.3 Blood Proteomics Services Market: Overall Company Footprint Analysis
    • 3.3.1 Blood Proteomics Services Market: Region Footprint
    • 3.3.2 Blood Proteomics Services Market: Company Product Type Footprint
    • 3.3.3 Blood Proteomics Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Blood Proteomics Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Blood Proteomics Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Blood Proteomics Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Blood Proteomics Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Blood Proteomics Services Consumption Value by Type (2021-2032)
  • 6.2 North America Blood Proteomics Services Market Size by Application (2021-2032)
  • 6.3 North America Blood Proteomics Services Market Size by Country
    • 6.3.1 North America Blood Proteomics Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Blood Proteomics Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Blood Proteomics Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Blood Proteomics Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Blood Proteomics Services Market Size by Country
    • 7.3.1 Europe Blood Proteomics Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Blood Proteomics Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Blood Proteomics Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Blood Proteomics Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Blood Proteomics Services Market Size by Region
    • 8.3.1 Asia-Pacific Blood Proteomics Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Blood Proteomics Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Blood Proteomics Services Consumption Value by Type (2021-2032)
  • 9.2 South America Blood Proteomics Services Consumption Value by Application (2021-2032)
  • 9.3 South America Blood Proteomics Services Market Size by Country
    • 9.3.1 South America Blood Proteomics Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Blood Proteomics Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Blood Proteomics Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Blood Proteomics Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Blood Proteomics Services Market Size by Country
    • 10.3.1 Middle East & Africa Blood Proteomics Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Blood Proteomics Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Blood Proteomics Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Blood Proteomics Services Market Drivers
  • 11.2 Blood Proteomics Services Market Restraints
  • 11.3 Blood Proteomics Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Blood Proteomics Services Industry Chain
  • 12.2 Blood Proteomics Services Upstream Analysis
  • 12.3 Blood Proteomics Services Midstream Analysis
  • 12.4 Blood Proteomics Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Blood Proteomics Services. Industry analysis & Market Report on Blood Proteomics Services is a syndicated market report, published as Global Blood Proteomics Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Blood Proteomics Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo